Changes in nursing practice for patients undergoing high dose therapy with peripheral blood stem cell support.

被引:0
|
作者
Brangan, E
Gupta, RK
机构
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
[2] St James Hosp, Dept Haematol, Dublin 8, Ireland
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
N920
引用
收藏
页码:S246 / S246
页数:1
相关论文
共 50 条
  • [1] Monitoring of minimal disease in patients with follicular non-Hodgkin's lymphoma undergoing high-dose therapy with peripheral blood stem cell support.
    Moos, M
    Schulz, R
    Murea, S
    Goldschmidt, H
    Haas, R
    BLOOD, 1997, 90 (10) : 340 - 340
  • [2] Immune reconstitution after high dose therapy with autologous blood stem cell support.
    Steingrimsdottir, H
    Gruber, A
    Bjorkholm, M
    Svensson, A
    Hansson, M
    BONE MARROW TRANSPLANTATION, 1998, 21 : S130 - S130
  • [3] Oxidative stress in patients undergoing high-dose therapy with autologous peripheral blood stem cell transplantation
    Arpaci, F
    Yilmaz, I
    Gursoy, M
    Ozet, A
    Beyzadeoglu, M
    Komurcu, S
    Ozturk, B
    Akay, C
    Ataergin, S
    Kuzhan, O
    Saglam, K
    BONE MARROW TRANSPLANTATION, 2003, 31 : S245 - S245
  • [4] Duration of T(14;18) PCR-negativity as prognostic parameter in patients with follicular non Hodgkin's lymphoma undergoing high-dose therapy with peripheral blood stem cell support.
    Moos, M
    Schulz, R
    Murea, S
    Haas, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S174 - S174
  • [5] Grading of mucositis in patients receiving high-dose therapy with autologous or allogeneic stem cell support.
    Borén, S
    Berndtson, M
    Gustavsson, C
    Juliusson, G
    BONE MARROW TRANSPLANTATION, 1998, 21 : S247 - S247
  • [6] Exercise therapy in multiple myeloma patients undergoing high dose chemotherapy and peripheral blood stem cell transplant.
    Coleman, EA
    Coon, SK
    Hall-Barrow, JC
    Gerlinger, JM
    Anaissie, EJ
    Richards, KC
    Evans, WJ
    BLOOD, 1999, 94 (10) : 297B - 297B
  • [7] Psychological evaluation of patients treated with high dose chemotherapy and autologous peripheral stem cells support.
    Orlando, L
    Gadda, B
    Casellato, L
    Bredart, A
    Didier, F
    Roveda, L
    Colombi, FB
    Scaffidi, E
    Di Leverano, C
    Magri, R
    Compare, L
    Labò, M
    Cocquio, A
    Peccatori, F
    Cinieri, S
    Ferrucci, PF
    Martinelli, G
    BONE MARROW TRANSPLANTATION, 1999, 23 : S258 - S258
  • [8] Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
    Hohaus, S
    Martin, S
    Schneeweiss, A
    Voso, MT
    Schlenk, RF
    Wallwiener, D
    Bastert, G
    Haas, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 44 (Suppl 1) : S13 - S17
  • [9] Adjuvant high-dose therapy with peripheral blood stem cell support for patients with high-risk breast cancer
    S. Hohaus
    S. Martin
    A. Schneeweiß
    M. T. Voso
    R. F. Schlenk
    D. Wallwiener
    G. Bastert
    R. Haas
    Cancer Chemotherapy and Pharmacology, 1999, 44 : S13 - S17
  • [10] Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support
    G. Egerer
    H. Goldschmidt
    N. Streich
    I. Ehrhard
    H. G. Sonntag
    R. Haas
    Supportive Care in Cancer, 1999, 7 : 336 - 342